Back to Investors
HC

Heal Capital

Venture Capital

Heal Capital is an investment firm that backs technology companies focused on bringing healthcare closer to home.

Portfolio

3

companies

AUM

£100M

under management


Portfolio companies

HH

Heim Health

A software platform powering at-home healthcare delivery.

Paloma Health

Paloma Health

Paloma Health deploys artificial intelligence to cut National Health Service waiting lists for autism assessments.

S

Sanome

Sanome develops an engine for clinically validated home testing diagnostics.


Team

Eckhardt Weber

Eckhardt Weber

Eckhardt Weber

Eckhardt brings venture capital and operational experience from roles at Heal Capital, Heartbeat Labs, and FinLeap. He previously served on the board of PAIR Finance.

LinkedIn
CW

Christian Weiß

Managing Partner

Christian serves as managing partner at Heal Capital, alongside advisory and investing roles across several ventures. He brings experience from the DARI Foundation, Freedom Vault, naturalX Health Ventures, and FORMEL Skin.

LinkedIn
MM

Marta Mrozowicz

Investment Manager


Recent investments

Seed
£2.2M

The seed round was led by Heal Capital to support platform development and expand community-based care pathways.

"For a long time, healthcare was rooted in the community. This brought so many benefits to both patients and practitioners, but in recent decades it’s become completely cost-ineffective to deliver it. Meanwhile, secondary care is becoming increasingly bottlenecked, with waiting lists at an all-time high and discharge delays keeping patients in hospital longer than they need. Our mission with Heim Health is to build the digital infrastructure needed to change this; revitalising community-based care and moving more healthcare from the hospital into the home through scalable modes of delivery."
— Kelly Klifa, Co-Founder and CEO
Pre-Seed
£2.0M

The pre-seed round was led by Triple Point Ventures to roll out autism assessment services.

"The current waiting times for autism assessments are very disappointing, with most families facing years of uncertainty. Our expert clinicians and engineers have redesigned the care pathway to offer families timely access to high-quality NHS care. This funding allows us to change the lives of many families, and support the NHS to tackle waiting lists."
— Mark Jenkins, Co-Founder and CEO
Pre-Seed
£2.0M

The funding round was led by Heal Capital and will support team expansion and product development.

"Healthcare touches each and every one of us and the recent pandemic has highlighted that at a global level. It showed the need to bring healthcare closer to people’s homes and that we need to leverage many of the recent innovations in digital health and consumer biotech to capture as many data points about human health as possible. This will transform our understanding of the human body and our approach to disease detection and management. At Sanome we are working toward developing multiple at home health tools to drive disruption within the healthcare landscape to benefit each one of us"
— Benedikt von Thüngen, CEO